Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients

Recruiting
18 years - 99 years
All
Phase 3
5 participants needed
1 Location

Brief description of study

The research study is being conducted to investigate the potential benefits of Enzastaurin in combination with temozolomide and radiation therapy in newly-diagnosed glioblastoma patients with the Denovo Genomic Marker1 (DGM1).

Detailed description of study

The research study is being conducted to investigate the potential benefits of Enzastaurin in combination with temozolomide and radiation therapy in newly-diagnosed glioblastoma patients with the Denovo Genomic Marker1 (DGM1). If you agree to join the study, you will be asked to complete the following research procedures: meet with physician investigator, meet with the study team to review the informed consent form, complete MRI of the head, complete blood work, provide a urine sample, complete an electrocardiogram (ECG), and collect vital signs. Your participation will last for approximately 25 months (including treatment and follow-up). Your participation may be shorter or longer, depending on how your tumor responds to treatment. The clinical trial is divided into 5 different sections: (1)

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Glioblastoma, Radiation Therapy
  • Age: 18 years - 99 years
  • Gender: All

Newly diagnosed patient with glioblastoma (GBM) that has elected to pursue temozolomide with radiation therapy as treatment plan post-surgery.

Updated on 04 Aug 2024. Study ID: 848849

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center